Modern Healthcare - - LATE NEWS -

Oba­macare re­mains un­pop­u­lar, but spe­cific pro­vi­sions of the fed­eral health­care law have broad support, ac­cord­ing to the lat­est polling data from the Kaiser Fam­ily Foun­da­tion. At least 75% of re­spon­dents ex­pressed support for health in­surance ex­changes, sub­si­dies for low-in­come house­holds and Med­i­caid ex­pan­sion. The em­ployer man­date, which takes ef­fect next year for com­pa­nies with at least 100 work­ers, was backed by 60% of re­spon­dents. One pro­vi­sion that failed to re­ceive majority support was the in­di­vid­ual man­date. De­spite strong support for the most sig­nif­i­cant pro­vi­sions of the Pa­tient Pro­tec­tion and Af­ford­able Care, the pub­lic still holds an un­fa­vor­able view of the land­mark health­care law. Just 41% ex­pressed support for the ACA, com­pared with 46% who op­posed it.

The av­er­age price paid by hos­pi­tals for drug-elut­ing stents fell 6% over the past year, as hos­pi­tals con­tinue to push back on the prices of physi­cian-pref­er­ence items, ac­cord­ing to the Mod­ern Health­care/ECRI In­sti­tute Tech­nol­ogy Price In­dex. The av­er­age price for a drug-elut­ing stent is $1,340, said Amanda McShea, a man­ager for ECRI’s Price-Guide ser­vice. But what hos­pi­tals pay for stents varies widely, be­cause of dif­fer­ences in their prod­uct ne­go­ti­a­tions. Also, the common dis­clo­sure clauses in­cluded in prod­uct con­tracts pre­vent some hos­pi­tals from shar­ing pric­ing. Hos­pi­tals pay be­tween $1,000 and $2,750 for a drug-elut­ing stent, based on ECRI In­sti­tute data.

A for­mer vice pres­i­dent of Rite Aid Corp. and his business as­so­ciate have signed ten­ta­tive plea agree­ments in a case that in­volved dup­ing the company out of $14.6 mil­lion by profit­ing from de­cep­tive sales of its sur­plus inventory. For­mer Rite Aid Vice Pres­i­dent Ti­mothy Foster and New Jersey busi­ness­man Jay Fin­dling al­legedly made Rite Aid be­lieve its sur­plus inventory had been sold to Fin­dling’s company for one price, when it had ac­tu­ally been sold to third par­ties for higher prices be­tween 2001 and 2010.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.